229 related articles for article (PubMed ID: 27172381)
21. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
Guilhaumou R; Marsot A; Dupouey J; Galambrun C; Boulamery A; Coze C; Simon N; André N
Ther Drug Monit; 2016 Oct; 38(5):559-66. PubMed ID: 27631462
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.
Shimamoto Y; Fukuda T; Tanaka K; Komori K; Sadamitsu D
Intensive Care Med; 2013 Jul; 39(7):1247-52. PubMed ID: 23604132
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
[TBL] [Abstract][Full Text] [Related]
24. Involvement of the effect of renal hypoperfusion medications on vancomycin trough concentration: A secondary analysis using a retrospective observational data.
Hirai T; Hanada K; Iwamoto T; Itoh T
Basic Clin Pharmacol Toxicol; 2021 Nov; 129(5):376-384. PubMed ID: 34396691
[TBL] [Abstract][Full Text] [Related]
25. Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.
Shigemura K; Osawa K; Yamamichi F; Tanaka K; Tokimatsu I; Arakawa S; Fujisawa M
Int Urol Nephrol; 2015 Jun; 47(6):887-91. PubMed ID: 25899764
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
27. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
[TBL] [Abstract][Full Text] [Related]
28. Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane.
Tsuruyama M; Yamashina T; Tsuruta M; Tsukada H; Fujimoto A; Nagano M; Kawamata Y; Takashima S; Hiraki Y
J Clin Pharm Ther; 2020 Oct; 45(5):1143-1148. PubMed ID: 32497268
[TBL] [Abstract][Full Text] [Related]
29. Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin.
Minkutė R; Briedis V; Steponavičiūtė R; Vitkauskienė A; Mačiulaitis R
J Clin Pharm Ther; 2013 Dec; 38(6):462-7. PubMed ID: 23924288
[TBL] [Abstract][Full Text] [Related]
30. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
[TBL] [Abstract][Full Text] [Related]
31. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?
Dhont E; Van Der Heggen T; De Jaeger A; Vande Walle J; De Paepe P; De Cock PA
Pediatr Nephrol; 2020 Jan; 35(1):25-39. PubMed ID: 30374606
[TBL] [Abstract][Full Text] [Related]
32. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
[TBL] [Abstract][Full Text] [Related]
33. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin dosing in neutropenic patients.
Haeseker MB; Croes S; Neef C; Bruggeman CA; Stolk LM; Verbon A
PLoS One; 2014; 9(11):e112008. PubMed ID: 25390637
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study.
Huang GM; Qiu Y; Liu TT; Lu JJ
J Clin Pharmacol; 2022 Jul; 62(7):863-872. PubMed ID: 35049078
[TBL] [Abstract][Full Text] [Related]
36. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
37. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
Sridharan K; Abbasi MY; Mulubwa M
Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
[TBL] [Abstract][Full Text] [Related]
39. A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance.
He J; Yang ZT; Qian X; Zhao B; Mao EQ; Chen EZ; Bian XL
Transl Androl Urol; 2020 Oct; 9(5):2166-2171. PubMed ID: 33209680
[TBL] [Abstract][Full Text] [Related]
40. Scoping review of augmented renal clearance in critically ill pediatric patients.
Rhoney DH; Metzger SA; Nelson NR
Pharmacotherapy; 2021 Oct; 41(10):851-863. PubMed ID: 34431121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
